Home

Articles

Biotech in the Middle Kingdom Highlights Rules of Engagement in China

For companies looking to partner in China, they must first realize the unique needs of this market.

Farm Bill Energy Title Programs: Timeline of a Successful Policy Initiative

Energy Programs Spur Growth in Industrial Biotech Industry

“Farm Bill Energy Title Programs: Timeline of a Successful Policy Initiative” (download PDF) is a visual representation of the progress and results of Farm Bill energy programs. It shows commercial biorefineries across the United States, some of which have been operating for as many as 10 years and others that are under construction.

The Renewable Fuel Standard: Timeline of a Successful Policy

“The Renewable Fuel Standard: Timeline of a Successful Policy” is a visual representation of the progress and results of the Renewable Fuel Standard (RFS).

Manager, Federal Government Relations

Department: Federal Government Relations 

Reports to: Senior Director, Federal Government Relations 

Primary Purpose of the Position:  

This position will help manage BIO’s federal government relations lobbying and research efforts related to biopharmaceutical issues including Medicare/Medicaid reimbursement, the FDA drug approval process, and implementation of health care reform. 

 Responsibilities:

The Economic Contribution of University/Nonprofit Inventions in the United States: 1996-2010

Using an input output “I-O” approach to estimating the economic impact of academic licensing, and summing over the 15 years of available data for academic U.S. AUTM Survey respondents, the total contribution of these academic licensors to gross industry output ranges from $199B to $836B, in 2005 $US Dollars; contributions to GDP range from $86B to $388B, in 2005 $US Dollars.

Battelle/BIO State Bioscience Industry Development

At a time when the global economy struggles to recover from a severe recession and uncertainty remains regarding future economic growth, bioscience industry development is generating significant attention both globally and at home.

Taking Stock: How Global Biotechnology Benefits from Intellectual Property Rights

This report examines the role played by IPRs in both upstream and downstream phases of the research, development and commercialization of biotechnology products and provides a review and analysis of the existing body of knowledge concerning the role of IPRs.

Bringing Innovation to Neglected Disease Research and Development: Joint Report by BIO and BIO Ventures for Global Health

BIO Ventures for Global Health (BVGH) and the Biotechnology Industry Organization (BIO) have collaborated on a new report that builds upon the findings in BVGH’s previous analysis, Developing New Drugs and Vaccines for Neglected Diseases of the Poor: The Product Developer Landscape.

Case Studies for Global Health: Case Studies Focus on Role of Multi-Sector Collaborations to Address Global Health Challenges

Successful multi-sector global health programs engage partners and policymakers early, communicate openly and frequently with relevant stakeholders, and empower and involve communities, according to a website relaunched this week, Case Studies for Global Health.

Visible Progress in Biorefinery Commercialization

Commercial-scale advanced biofuel, renewable chemical, and biobased product biorefineries are in operation or under construction; pilot and demonstration projects continue to scale-up new technologies. 

Meet the BIO Official Bloggers

For the fourth year in a row, BIO is working with bloggers and reporters from around the country (and Canada) to provide attendees with an inside look of what’s happening in Boston.

Global Economic and Environmental Benefits of GE Crops Continues to Rise

Farmers using improved seeds and biotech crop varieties continue to see significant economic and on-farm environmental benefits.

Gene Patent Myths

Gene Patents and the Myriad patent case reveal the confusion that often occurs when you mix science, law, politics, and emotion. This article provides a digest of a series of blog posts on Biotech-Now that address common myths in the gene patent debate.

IFIC Survey Finds Consumers Support Current Food Labeling Policies

The International Food Information Council (IFIC) survey, “Consumer Perceptions of Food Technology & Sustainability”, shows U.S. consumers overwhelmingly support current federal rules for labeling foods. 

Biotechnology’s Impact on Food Ingredients

Natural biological processes have been employed for food production for more than 8,000 years. Bread, cheese, yogurt, beer and wine, vinegar, and many other foods are produced through microbial fermentation or enzymatic activity.

Ag Biotech: An Environmental Success Story

Biotech allows us to meet the food production demands of a growing population in an economical way while lessening environmental impact. 

Blockade of Learning and Memory Genes May Occur Early in Alzheimer's Disease

A repression of gene activity in the brain appears to be an early event affecting people with Alzheimer's disease, researchers funded by NIH have found.

NHLBI Scientists: Gene Therapy Helps Patients with Hemophilia

A single dose of an experimental gene therapy boosted production of a missing blood-clotting factor in people with hemophilia, a new study shows.

NIAID Studies Show Benefits of Immediate Anti-retroviral Treatment for HIV-infected Infants

Results from studies presented March 6 at the Conference on Retroviruses & Opportunistic Infections in Seattle demonstrated the importance of identifying & treating HIV-infected infants within the first year of life to prevent harm to the immune system & to enable normal neurological development.

NIAMS Scientists: RA Drug Halts Organ Damage in Inflammatory Genetic Disorder

A new study shows that Kineret (anakinra), a medication approved for the treatment of rheumatoid arthritis, is effective in stopping the progression of organ damage in people with neonatal-onset multisystem inflammatory disease (NOMID).

NIH Study to Test Treatment for Fatty Liver Disease in Children

With the launch of a new clinical trial supported by NIH, researchers are working to determine whether treating children diagnosed with the most severe form of fatty liver disease with a drug called cysteamine will help improve the liver.

Research Team Finds a New Breast Cancer Susceptibility Gene

Mutations in a gene called XRCC2 cause increased breast cancer risk, according to a study in the American Journal of Human Genetics.

Developing Policies that Foster Innovation

Acorda Therapeutics' Ron Cohen presented testimony on the importance of federal policies to support the biotechnology industry at a House Committee on Science, Space and Technology, Subcommittee on Technology and Innovation hearing on March 27, a summary of his testimony is presented here

The JOBS Act: Critical Support for Today’s Emerging Biotech Company

The House and Senate passed H.R. 3606, the Jumpstart Our Business Startups (JOBS) Act. It is now headed to the White House for President Obama’s signature.

Therapeutic Discovery Project: FAQs

In 2010, the Therapeutic Discovery Project (TDP) awarded $1 billion in tax credits to about 2,923 small biotechnology companies across the country to accelerate discovery of promising, cutting-edge cures to treat devastating diseases like cancer, heart disease, diabetes, and Alzheimer’s.